Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Ipca Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524494NSE Symbol: IPCALABP/E(TTM):43.35
ISIN Demat:INE571A01038Div & Yield %:0.28EPS(TTM):32.87
Book Value(Rs):271.6399623Market Cap ( Cr.):36149.05Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 6166.465814.625438.305139.164367.433633.15
Excise Duty0.000.000.000.0029.6127.49
Net Sales6166.465814.625438.305139.164337.823605.66
Other Income 111.29111.1952.9262.2464.6954.59
Stock Adjustments 55.19-104.09126.00170.73155.05106.14
Total Income6332.945821.725617.225372.134557.563766.39
EXPENDITURE :      
Raw Materials 2033.571964.941911.881753.211635.751265.89
Power & Fuel Cost253.33277.21237.44201.48196.82175.25
Employee Cost 1336.191193.391102.14948.84870.79752.24
Other Manufacturing Expenses 356.81311.74279.03225.25198.30168.78
Selling and Administration Expenses 846.95812.67612.89551.23523.99511.56
Miscellaneous Expenses 314.87236.31179.67113.31149.41142.31
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure5141.724796.264323.053793.323575.063016.03
Operating Profit1191.221025.461294.171578.81982.50750.36
Interest 122.5846.3410.4111.1318.8421.09
Gross Profit1068.64979.121283.761567.68963.66729.27
Depreciation246.48228.63209.65187.72178.69171.88
Profit Before Tax822.16750.491074.111379.96784.97557.39
Tax288.01223.95197.28244.98137.98102.48
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax3.7420.8416.46-5.79-5.470.00
Reported Net Profit530.41505.70860.371140.77652.46454.91
Extraordinary Items -69.5217.517.868.3410.866.30
Adjusted Net Profit599.93488.19852.511132.43641.60448.61
Adjst. below Net Profit -1.39-2.051.15-0.16-107.04-1.10
P & L Balance brought forward4478.524076.353316.312277.181752.531311.36
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 50.74101.48101.48101.4820.7712.64
P & L Balance carried down4956.804478.524076.353316.312277.181752.53
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %400.00400.00400.00400.00250.00150.00
Earnings Per Share-Unit Curr20.9119.9333.9189.9351.6436.00
Earnings Per Share(Adj)-Unit Curr20.9119.9333.9144.9725.8218.00
Book Value-Unit Curr250.24231.66215.84374.67290.11248.25